266 related articles for article (PubMed ID: 30452591)
21. Effectiveness of Intravitreal Ranibizumab for Diabetic Macular Edema with Serous Retinal Detachment.
Kaya M; Karahan E; Ozturk T; Kocak N; Kaynak S
Korean J Ophthalmol; 2018 Aug; 32(4):296-302. PubMed ID: 30091308
[TBL] [Abstract][Full Text] [Related]
22. Intravitreal ranibizumab for diabetic macular oedema in previously vitrectomized eyes.
Laugesen CS; Ostri C; Brynskov T; Lund-Andersen H; Larsen M; Vorum H; Sørensen TL
Acta Ophthalmol; 2017 Feb; 95(1):28-32. PubMed ID: 27473397
[TBL] [Abstract][Full Text] [Related]
23. Correlation between anterior chamber flare changes and diabetic macular edema after intravitreal injection of ranibizumab and aflibercept.
Shiraya T; Kure K; Araki F; Kato S; Kaiya T
Jpn J Ophthalmol; 2020 May; 64(3):250-256. PubMed ID: 32108920
[TBL] [Abstract][Full Text] [Related]
24. Imaging retinal inflammatory biomarkers after intravitreal steroid and anti-VEGF treatment in diabetic macular oedema.
Vujosevic S; Torresin T; Bini S; Convento E; Pilotto E; Parrozzani R; Midena E
Acta Ophthalmol; 2017 Aug; 95(5):464-471. PubMed ID: 27775223
[TBL] [Abstract][Full Text] [Related]
25. AQUEOUS HUMOR CYTOKINES AND THERAPEUTIC CUSTOMIZATION IN NONRESPONDING MACULAR EDEMA SECONDARY TO RETINAL VEIN OCCLUSION.
Modi A; Sharma K; Sudhakar NP; Yadav NK
Retin Cases Brief Rep; 2021 Mar; 15(2):127-130. PubMed ID: 30664079
[TBL] [Abstract][Full Text] [Related]
26. Correlation of Response between Both Eyes to First- and Second-Line Anti-VEGF Therapy in Diabetic Macular Edema.
Tiosano L; Ayalon A; Banin E; Averbukh E; Jaouni T; Chowers I
Curr Eye Res; 2021 Apr; 46(4):539-545. PubMed ID: 32804540
[TBL] [Abstract][Full Text] [Related]
27. Functional and morphological changes in diabetic macular edema over the course of anti-vascular endothelial growth factor treatment.
Reznicek L; Cserhati S; Seidensticker F; Liegl R; Kampik A; Ulbig M; Neubauer AS; Kernt M
Acta Ophthalmol; 2013 Nov; 91(7):e529-36. PubMed ID: 23647578
[TBL] [Abstract][Full Text] [Related]
28. Significance of monitoring vascular endothelial growth factor, monocyte chemoattractant protein-1 and Interleukin-8 in diabetic macular edema towards early identification of nonresponders to ranibizumab therapy.
Xavier T; Pallikara S; Saji N; Radhakrishnan N; Menon KN; Pillai GS
Indian J Ophthalmol; 2021 Jun; 69(6):1475-1481. PubMed ID: 34011723
[TBL] [Abstract][Full Text] [Related]
29. The macular function and structure in patients with diabetic macular edema before and after ranibizumab treatment.
Nowacka B; Kirkiewicz M; Mozolewska-Piotrowska K; Lubiński W
Doc Ophthalmol; 2016 Apr; 132(2):111-22. PubMed ID: 27000269
[TBL] [Abstract][Full Text] [Related]
30. Effect of Intravitreal Ranibizumab on Intraretinal Hard Exudates in Eyes with Diabetic Macular Edema.
Srinivas S; Verma A; Nittala MG; Alagorie AR; Nassisi M; Gasperini J; Sadda SR
Am J Ophthalmol; 2020 Mar; 211():183-190. PubMed ID: 31758926
[TBL] [Abstract][Full Text] [Related]
31. A prospective randomized trial of intravitreal bevacizumab versus ranibizumab for the management of diabetic macular edema.
Nepomuceno AB; Takaki E; Paes de Almeida FP; Peroni R; Cardillo JA; Siqueira RC; Scott IU; Messias A; Jorge R
Am J Ophthalmol; 2013 Sep; 156(3):502-510.e2. PubMed ID: 23795985
[TBL] [Abstract][Full Text] [Related]
32. Conversion to Aflibercept After Prior Anti-VEGF Therapy for Persistent Diabetic Macular Edema.
Rahimy E; Shahlaee A; Khan MA; Ying GS; Maguire JI; Ho AC; Regillo CD; Hsu J
Am J Ophthalmol; 2016 Apr; 164():118-27.e2. PubMed ID: 26748058
[TBL] [Abstract][Full Text] [Related]
33. Effect of intravitreal triamcinolone in diabetic macular edema unresponsive to intravitreal bevacizumab.
Jeon S; Lee WK
Retina; 2014 Aug; 34(8):1606-11. PubMed ID: 24553409
[TBL] [Abstract][Full Text] [Related]
34. Effect of Vitreomacular Adhesion on Treatment Outcomes in the Ranibizumab for Edema of the Macula in Diabetes (READ-3) Study.
Sadiq MA; Soliman MK; Sarwar S; Agarwal A; Hanout M; Demirel S; Rentiya ZS; Khan W; Do DV; Nguyen QD; Sepah YJ;
Ophthalmology; 2016 Feb; 123(2):324-329. PubMed ID: 26520169
[TBL] [Abstract][Full Text] [Related]
35. Relationship between aqueous humor cytokine level changes and retinal vascular changes after intravitreal aflibercept for diabetic macular edema.
Mastropasqua R; D'Aloisio R; Di Nicola M; Di Martino G; Lamolinara A; Di Antonio L; Tognetto D; Toto L
Sci Rep; 2018 Nov; 8(1):16548. PubMed ID: 30410092
[TBL] [Abstract][Full Text] [Related]
36. Simultaneous Inhibition of Angiopoietin-2 and Vascular Endothelial Growth Factor-A with Faricimab in Diabetic Macular Edema: BOULEVARD Phase 2 Randomized Trial.
Sahni J; Patel SS; Dugel PU; Khanani AM; Jhaveri CD; Wykoff CC; Hershberger VS; Pauly-Evers M; Sadikhov S; Szczesny P; Schwab D; Nogoceke E; Osborne A; Weikert R; Fauser S
Ophthalmology; 2019 Aug; 126(8):1155-1170. PubMed ID: 30905643
[TBL] [Abstract][Full Text] [Related]
37. Aflibercept, Bevacizumab, or Ranibizumab for Diabetic Macular Edema: Two-Year Results from a Comparative Effectiveness Randomized Clinical Trial.
Wells JA; Glassman AR; Ayala AR; Jampol LM; Bressler NM; Bressler SB; Brucker AJ; Ferris FL; Hampton GR; Jhaveri C; Melia M; Beck RW;
Ophthalmology; 2016 Jun; 123(6):1351-9. PubMed ID: 26935357
[TBL] [Abstract][Full Text] [Related]
38. Anatomic Response to Intravitreal Dexamethasone Implant and Baseline Aqueous Humor Cytokine Levels in Diabetic Macular Edema.
Figueras-Roca M; Sala-Puigdollers A; Zarranz-Ventura J; Alba-Linero C; Alforja S; Esquinas C; Molins B; Adán A
Invest Ophthalmol Vis Sci; 2019 Apr; 60(5):1336-1343. PubMed ID: 30933261
[TBL] [Abstract][Full Text] [Related]
39. Comparison of 12-month therapeutic effect of conbercept and ranibizumab for diabetic macular edema: a real-life clinical practice study.
Xu Y; Rong A; Xu W; Niu Y; Wang Z
BMC Ophthalmol; 2017 Aug; 17(1):158. PubMed ID: 28841827
[TBL] [Abstract][Full Text] [Related]
40. Intravitreal bevacizumab and cytokine levels in major and macular branch retinal vein occlusion.
Lim JW
Ophthalmologica; 2011; 225(3):150-4. PubMed ID: 21150231
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
